Amprius Technologies (NYSE:AMPX) Given New $15.00 Price Target at Needham & Company LLC

Amprius Technologies (NYSE:AMPX) had its price target cut by equities research analysts at Needham & Company LLC from $20.00 to $15.00 in a research report issued on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC‘s price target would indicate a potential upside of 75.21% from the stock’s current price.

Other analysts have also recently issued reports about the company. UBS Group restated an “outperform” rating on shares of Amprius Technologies in a report on Friday, November 6th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Amprius Technologies in a report on Thursday, October 15th. HC Wainwright reiterated a “buy” rating and set a $18.00 price target on shares of Amprius Technologies in a report on Tuesday, September 29th. Zacks Research raised shares of Amprius Technologies from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 4th. Finally, National Bank Financial set a $18.00 price objective on shares of Amprius Technologies in a report on Tuesday, September 29th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Amprius Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $21.00.

Amprius Technologies Price Performance

Shares of Amprius Technologies stock opened at $8.56 on Wednesday. The stock’s 50 day simple moving average is $9.06 and its 200-day simple moving average is $13.21. The stock has a market cap of $1.21 billion, a P/E ratio of -30.57 and a beta of 2.36. Amprius Technologies has a 1-year low of $7.02 and a 1-year high of $24.23.

Amprius Technologies (NYSE:AMPX) last posted its quarterly earnings results on Tuesday, November 10th. The company reported ($0.02) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.01). Amprius Technologies had a negative net margin of 29.94% and a negative return on equity of 12.01%. The company had revenue of $39.15 million during the quarter, compared to analyst estimates of $35.80 million. During the same period in the prior year, the business posted ($0.03) EPS. As a group, research analysts expect that Amprius Technologies will post -0.08 EPS for the current fiscal year.

Insider Buying and Selling at Amprius Technologies

In other news, CTO Constantin Stefan sold 29,681 shares of the stock in a transaction on Friday, August 21st. The stock was sold at an average price of $10.34, for a total transaction of $306,901.54. Following the completion of the transaction, the chief technology officer directly owned 771,629 shares in the company, valued at approximately $7,978,643.86. This represents a 3.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Thomas M. Stepien sold 8,000 shares of the stock in a transaction on Monday, August 24th. The stock was sold at an average price of $10.03, for a total value of $80,240.00. Following the transaction, the chief executive officer owned 594,096 shares of the company’s stock, valued at approximately $5,958,782.88. This represents a 1.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 123,311 shares of company stock worth $1,272,556 over the last quarter. 5.10% of the stock is currently owned by company insiders.

Institutional Trading of Amprius Technologies

Institutional investors and hedge funds have recently bought and sold shares of the stock. Stephens Investment Management Group LLC lifted its position in Amprius Technologies by 517.1% in the third quarter. Stephens Investment Management Group LLC now owns 4,408,140 shares of the company’s stock valued at $42,671,000 after buying an additional 3,693,816 shares during the last quarter. Russell Investments Group Ltd. increased its position in shares of Amprius Technologies by 192.1% during the third quarter. Russell Investments Group Ltd. now owns 592,881 shares of the company’s stock valued at $5,739,000 after acquiring an additional 389,922 shares during the last quarter. Allspring Global Investments Holdings LLC increased its position in shares of Amprius Technologies by 700.2% during the first quarter. Allspring Global Investments Holdings LLC now owns 431,398 shares of the company’s stock valued at $6,695,000 after acquiring an additional 377,485 shares during the last quarter. First Trust Advisors LP increased its position in shares of Amprius Technologies by 1,105.0% during the first quarter. First Trust Advisors LP now owns 394,569 shares of the company’s stock valued at $6,652,000 after acquiring an additional 361,825 shares during the last quarter. Finally, Wellington Management Group LLP purchased a new stake in shares of Amprius Technologies in the 2nd quarter valued at approximately $4,751,000. 5.04% of the stock is currently owned by hedge funds and other institutional investors.

Latest Amprius Technologies News

Investors following AMPX have been watching these news items:

• Positive Sentiment: Third-quarter revenue reached a record $39.1 million, up 83% year over year and ahead of analyst estimates. Gross profit also increased substantially. Amprius Q3 results
• Positive Sentiment: The company set a 2026 revenue target of $145 million, above the roughly $140.6 million consensus, and plans U.S. pouch-cell capacity of 12 million cells annually by early 2028. Revenue target and capacity plans
• Negative Sentiment: Amprius reported a Q3 loss of $0.02 per share, missing the $0.01 loss analysts expected. Freight costs also weighed on margins, while the company used $7.8 million in operating cash. The earnings miss and cost concerns prompted a negative market reaction after results. Q3 earnings call transcript

Amprius Technologies Company Profile

Amprius Technologies, Inc. develops and manufactures lithium-ion batteries designed to provide high energy density and power. Its battery technology uses silicon-based anodes, an alternative to the graphite anodes commonly used in conventional lithium-ion cells. The company’s products are designed for applications where low weight and high performance are important, including electric aviation, drones, aerospace, defense and other mobility markets. Amprius offers silicon-anode cells for customers developing these systems.